Report Format:  
| Pages: 160+
Type: Niche Industry Monitor
| ID: DEF4717
| Publication: April 2025
|
US$1,345 |
The North America CBRN (chemical, biological, radiological, and nuclear) defence market is experiencing robust growth, fuelled by rising geopolitical tensions and heightened defence investments focused on modernizing defence capabilities across the region. The United States leads the region, with substantial defence budgets allocated towards enhancing CBRN capabilities. In 2024, the U.S. Department of Defence awarded a $235.8 million contract to Emergent BioSolutions for the supply of BioThrax® to bolster biodefense measures across all military branches. Canada is also making strides, with Prime Minister Mark Carney unveiling a defence plan in April 2025 that includes C$30.9 billion in military spending over four years, aiming to meet NATO's 2% GDP target by 2030. Additionally, Mexico, recognizing the importance of regional collaboration, participated in the bilateral Exercise Fuerzas Amigas 2024 with the U.S., focusing on joint CBRN preparedness and response strategies. These developments underscore a collective commitment across North America to bolster CBRN defence infrastructure, ensuring readiness against evolving threats.
The increasing threat of CBRN incidents, both from state and non-state actors, necessitating enhanced defence mechanisms drive the growth of the market in North America region. The U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defence (JPEO-CBRND) awarded a $53 million contract to Battelle in September 2024 to develop an improved nerve agent countermeasure, highlighting the emphasis on advanced medical countermeasures. Additionally, the Defence Threat Reduction Agency (DTRA) awarded a multiple-award contract with a maximum cumulative ceiling of $4 billion in May 2024, focusing on research and development to combat weapons of mass destruction, including CBRN threats. Canada's defence strategy includes significant investments in Arctic defence, with plans to procure submarines, icebreakers, drones, and radar systems, emphasizing the importance of sovereignty and preparedness in the face of emerging threats. Moreover, Mexico's participation in joint exercises with the U.S. military enhances interoperability and readiness, reflecting a regional approach to addressing shared CBRN challenges.
The North American CBRN defence industry is witnessing transformative trends, marked by technological advancements and increased collaboration. The U.S. Department of Defence emphasis on rapid development and deployment of advanced CBRN defence systems is evident in initiatives like the $900 million multiple-award contract secured by Science Applications International Corp. (SAIC) in 2024, providing comprehensive CBRN support to U.S. military services. In Canada, the defence plan unveiled in April 2025 includes investments in emerging technologies such as artificial intelligence and quantum computing, aiming to enhance CBRN defence capabilities. Mexico focuses on developing smart sensors and automated decontamination solutions, as well as advancements in unmanned aerial systems and robotics, reflects a commitment to modernizing CBRN defence infrastructure. These trends collectively indicate a regional move towards a more agile, technologically advanced, and collaborative CBRN defence posture.?
Recent developments in the North America CBRN defence market underscore a proactive approach to enhancing regional security. Teledyne FLIR Defence made headlines in April 2025 by securing a $74.2 million contract from the U.S. Army to upgrade the sensor suite of the M1135 Stryker Nuclear, Biological, and Chemical Reconnaissance Vehicle (NBCRV). This next-generation system will integrate autonomous detection tools such as the R80D SkyRaider™ drone with the MUVE™ B330 payload for biological agent identification, alongside a newly developed command-and-control platform to streamline operator decision-making through real-time sensor fusion. Adding to the momentum, AirBoss Defense Group landed a significant $36.5 million contract to supply next-generation CBRN protective gloves for U.S. forces, reinforcing frontline readiness and troop safety in hazardous environments.
In a separate deal from late 2024, AirBoss also secured an $84 million contract from the U.S. Department of Health and Human Services for the delivery of isolation gowns, strengthening national preparedness for biological threats and pandemics. These recent developments reflect a sharp uptick in North America's strategic defense procurement aimed at modernizing CBRN capabilities through a combination of AI-driven systems, autonomous platforms, and advanced personal protective equipment—affirming the region’s commitment to staying ahead of evolving chemical and biological threats.